CASI Pharmaceuticals Operating Expenses Growth & History (CASIF)

CASI Pharmaceuticals's operating expenses was $55.1M for fiscal 2025.

View full CASI Pharmaceuticals company overview

CASI Pharmaceuticals annual operating expenses history

CASI Pharmaceuticals annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31$55.1M$4.3M+8.50%
20242024-12-31$50.8M$5.6M+12.49%
20232023-12-31$45.1M−$16.2M−26.39%
20222022-12-31$61.3M$2.2M+3.70%
20212021-12-31$59.1M$713,000+1.22%
20202020-12-31$58.4M

CASI Pharmaceuticals operating expenses trends

Over the last five fiscal years, CASI Pharmaceuticals's operating expenses decreased from $58.4M to $55.1M, a change of −$3.3M. The latest reported quarter, Q4 2025, shows $15.3M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review CASI Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about CASIF yet. Start the conversation.

Write the first post